A detailed history of Vanguard Group Inc transactions in Blue Water Vaccines Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 73,513 shares of BWV stock, worth $12,497. This represents 0.0% of its overall portfolio holdings.

Number of Shares
73,513
Previous 73,513 -0.0%
Holding current value
$12,497
Previous $14,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.18 - $0.52 $21,955 - $63,426
-121,974 Reduced 62.39%
73,513 $14,000
Q3 2023

Nov 14, 2023

BUY
$0.51 - $1.2 $9,284 - $21,844
18,204 Added 10.27%
195,487 $99,000
Q2 2023

Aug 14, 2023

BUY
$0.79 - $1.29 $316 - $516
400 Added 0.23%
177,283 $200,000
Q1 2023

May 15, 2023

BUY
$1.01 - $1.56 $133,110 - $205,597
131,793 Added 292.29%
176,883 $189,000
Q3 2022

Nov 14, 2022

BUY
$1.78 - $6.66 $80,260 - $300,299
45,090 New
45,090 $77,000

Others Institutions Holding BWV

About Blue Water Vaccines Inc.


  • Ticker BWV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,744,900
  • Market Cap $2.34M
  • Description
  • Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical de...
More about BWV
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.